156 related articles for article (PubMed ID: 12814799)
1. Candidate chromosomal regions for genes involved in activation of alternative lengthening of telomeres in human immortal cell lines.
Shigeeda N; Uchida M; Barrett JC; Tsutsui T
Exp Gerontol; 2003 Jun; 38(6):641-51. PubMed ID: 12814799
[TBL] [Abstract][Full Text] [Related]
2. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
[TBL] [Abstract][Full Text] [Related]
3. Immortal, telomerase-negative cell lines derived from a Li-Fraumeni syndrome patient exhibit telomere length variability and chromosomal and minisatellite instabilities.
Tsutsui T; Kumakura S; Tamura Y; Tsutsui TW; Sekiguchi M; Higuchi T; Barrett JC
Carcinogenesis; 2003 May; 24(5):953-65. PubMed ID: 12771041
[TBL] [Abstract][Full Text] [Related]
4. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
Grobelny JV; Kulp-McEliece M; Broccoli D
Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
[TBL] [Abstract][Full Text] [Related]
5. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes.
Loughran O; Clark LJ; Bond J; Baker A; Berry IJ; Edington KG; Ly IS; Simmons R; Haw R; Black DM; Newbold RF; Parkinson EK
Oncogene; 1997 Apr; 14(16):1955-64. PubMed ID: 9150362
[TBL] [Abstract][Full Text] [Related]
7. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit.
Bryan TM; Marusic L; Bacchetti S; Namba M; Reddel RR
Hum Mol Genet; 1997 Jun; 6(6):921-6. PubMed ID: 9175740
[TBL] [Abstract][Full Text] [Related]
8. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
9. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR
J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680
[TBL] [Abstract][Full Text] [Related]
10. Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells.
Kumakura S; Tsutsui TW; Yagisawa J; Barrett JC; Tsutsui T
Cancer Res; 2005 Apr; 65(7):2778-86. PubMed ID: 15805278
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.
Novakovic B; Napier CE; Vryer R; Dimitriadis E; Manuelpillai U; Sharkey A; Craig JM; Reddel RR; Saffery R
Mol Hum Reprod; 2016 Nov; 22(11):791-799. PubMed ID: 27604461
[TBL] [Abstract][Full Text] [Related]
12. Functional evidence for a squamous cell carcinoma mortality gene(s) on human chromosome 4.
Forsyth NR; Morrison V; Craig NJ; Fitzsimmons SA; Barr NI; Ireland H; Gordon KE; Dowen S; Cuthbert AP; Newbold RF; Bryce SD; Parkinson EK
Oncogene; 2002 Aug; 21(33):5135-47. PubMed ID: 12140764
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
Perrem K; Colgin LM; Neumann AA; Yeager TR; Reddel RR
Mol Cell Biol; 2001 Jun; 21(12):3862-75. PubMed ID: 11359895
[TBL] [Abstract][Full Text] [Related]
14. Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome.
Jeyapalan JN; Varley H; Foxon JL; Pollock RE; Jeffreys AJ; Henson JD; Reddel RR; Royle NJ
Hum Mol Genet; 2005 Jul; 14(13):1785-94. PubMed ID: 15888482
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activation in human fibroblasts during escape from crisis.
Montalto MC; Phillips JS; Ray FA
J Cell Physiol; 1999 Jul; 180(1):46-52. PubMed ID: 10362016
[TBL] [Abstract][Full Text] [Related]
16. Telomere maintenance by telomerase and by recombination can coexist in human cells.
Cerone MA; Londono-Vallejo JA; Bacchetti S
Hum Mol Genet; 2001 Sep; 10(18):1945-52. PubMed ID: 11555631
[TBL] [Abstract][Full Text] [Related]
17. TP53-dependent chromosome instability is associated with transient reductions in telomere length in immortal telomerase-positive cell lines.
Schwartz JL; Jordan R; Liber H; Murnane JP; Evans HH
Genes Chromosomes Cancer; 2001 Mar; 30(3):236-44. PubMed ID: 11170280
[TBL] [Abstract][Full Text] [Related]
18. Multiple pathways to cellular senescence: role of telomerase repressors.
Oshimura M; Barrett JC
Eur J Cancer; 1997 Apr; 33(5):710-5. PubMed ID: 9282109
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in hybrids between telomerase-negative and telomerase-positive immortal human cells is repressed in the different complementation groups but not in the same complementation group of immortality.
Ishii Y; Tsuyama N; Maeda S; Tahara H; Ide T
Mech Ageing Dev; 1999 Oct; 110(3):175-93. PubMed ID: 10576247
[TBL] [Abstract][Full Text] [Related]
20. Loss of wild-type ATRX expression in somatic cell hybrids segregates with activation of Alternative Lengthening of Telomeres.
Bower K; Napier CE; Cole SL; Dagg RA; Lau LM; Duncan EL; Moy EL; Reddel RR
PLoS One; 2012; 7(11):e50062. PubMed ID: 23185534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
